Measuring the unmeasurable: the role and importance of quality of life measurement in economic evaluations of sleep disorder treatment
European PsychiatryPublished 1 January 1995
J. Graf von der Schulenburg
Citations2
SJR quartileQ1
SJR score1.99
SNIP1.53
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The basic methods for evaluating the costs and benefits of treating sleep disorders are described and an appropriate treatment increases patients' quality of life and work productivity.
Abstract
Sleep disorder is a widespread chronic disease. Its treatment and the disease itself causes losses to society, eg treatment cost and cost of sick leaves. On the other hand an appropriate treatment increases patients' quality of life and work productivity. The basic methods for evaluating the costs and benefits of treating sleep disorders are described.
Keywords
PsychologyMedicineEconomics, Econometrics and Finance
Journal of the Royal Statistical Society Series A (Statistics in Society)Quality-of-Life Assessment: Can We Keep It Simple?
355 Citations1992D. R. Cox, Ray Fitzpatrick +4 more
The importance of general statistical principles of study design and analysis to quality-of-life assessment in clinical trials is emphasized and the use of simple weighting schemes supplemented by sensitivity analysis is suggested.
PharmacoEconomicsEconomic Evaluation of Pharmaceuticals
87 Citations1993Michael Drummond, Frans Rutten +9 more
The overriding conclusion is that economic evaluation of medicines is likely to be more relevant in Europe in the future, although the problem for the pharmaceutical industry is in determining when and how.
Social Science & MedicineEconomic evaluation in the development of medicines
35 Citations1989Burton A. Weisbrod
Health Care and Economic Aspects of the Quality of Life of Heart Failure Patients
2 Citations1991Wolfgang Pohl, J.‐Matthias Graf v. d. Schulenburg
Information regarding the quality of life and the burdens created by illness and disability in the lifespan preceding death is required.
